New Jersey communities will get $95 million to expand harm reduction services and otherwise battle addiction, under new funding state officials announced on Feb. 15, 2024. (Photo by Jeff J Mitchell/Getty Images)
New Jersey communities will get $95 million in national opioid settlement funds over the next three years to expand addiction treatment services and fight an opioid epidemic that contributed to more than 2,500 overdose deaths statewide last year, officials announced Thursday. Luer Lock Male Female
The funding is just the first batch of more than $1 billion pharmaceutical companies are expected to pay New Jersey over the next two decades to settle national lawsuits over their role in creating and fueling the opioid crisis.
“Importantly, half of that amount will go directly toward our counties and local governments so these funds can be spent quickly on the front lines of our communities,” Gov. Phil Murphy said during a morning news conference at a harm reduction center in Newark.
The state council tasked with advising policymakers how best to spend the money recommended officials first beef up harm reduction services statewide, so the biggest chunk of the funding Murphy announced — $24 million over two years — will expand such centers to 18 counties and fund harm-reduction supplies in especially drug-ravaged communities.
Until last year, just seven counties had these centers, where people can get clean needles, wound care, connections to treatment and other social services, and more. State lawmakers passed a law in January 2022 to remove restrictions that had prevented new harm reduction centers from opening; state health officials began accepting applications for new centers last July.
“Expanding support for our neighbors struggling with addiction, rather than throwing them behind bars, saves lives and improves community health more broadly,” Murphy said. “We know what works, what doesn’t work. We’re doubling down on what does work.”
The funding will also support:
Overdose deaths have fallen statewide from their record high of over 3,000 in 2021, but some alarming trends persist, said Kaitlan Baston, the acting state health commissioner.
“While we are flattening the curve for some, we are not flattening the curve for all,” Baston said. “As we’ve seen the numbers drop off for white New Jerseyans, we’ve actually seen them continue to rise in the Black and brown communities in our state, which is unacceptable. And we’re seeing disproportionate amounts of people really affected in rural areas and staggering numbers in the elderly population. And so I say all this not to be depressing, but to say we have work to do, and that is why we are here.”
Addiction recovery providers and advocates applauded the news.
“These recommendations are exactly the types of services we should be funding if we want to save as many lives as possible,” said Eddie Frierson of the New Jersey Harm Reduction Coalition. “Harm reduction is the best tool we have to prevent overdose deaths, and we have mountains of evidence and personal experience to prove it. Now we just need more dollars so every community in the state has access to this lifesaving care.”
GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
by Dana DiFilippo, New Jersey Monitor February 15, 2024
by Dana DiFilippo, New Jersey Monitor February 15, 2024
New Jersey communities will get $95 million in national opioid settlement funds over the next three years to expand addiction treatment services and fight an opioid epidemic that contributed to more than 2,500 overdose deaths statewide last year, officials announced Thursday.
The funding is just the first batch of more than $1 billion pharmaceutical companies are expected to pay New Jersey over the next two decades to settle national lawsuits over their role in creating and fueling the opioid crisis.
“Importantly, half of that amount will go directly toward our counties and local governments so these funds can be spent quickly on the front lines of our communities,” Gov. Phil Murphy said during a morning news conference at a harm reduction center in Newark.
The state council tasked with advising policymakers how best to spend the money recommended officials first beef up harm reduction services statewide, so the biggest chunk of the funding Murphy announced — $24 million over two years — will expand such centers to 18 counties and fund harm-reduction supplies in especially drug-ravaged communities.
Until last year, just seven counties had these centers, where people can get clean needles, wound care, connections to treatment and other social services, and more. State lawmakers passed a law in January 2022 to remove restrictions that had prevented new harm reduction centers from opening; state health officials began accepting applications for new centers last July.
“Expanding support for our neighbors struggling with addiction, rather than throwing them behind bars, saves lives and improves community health more broadly,” Murphy said. “We know what works, what doesn’t work. We’re doubling down on what does work.”
The funding will also support:
Overdose deaths have fallen statewide from their record high of over 3,000 in 2021, but some alarming trends persist, said Kaitlan Baston, the acting state health commissioner.
“While we are flattening the curve for some, we are not flattening the curve for all,” Baston said. “As we’ve seen the numbers drop off for white New Jerseyans, we’ve actually seen them continue to rise in the Black and brown communities in our state, which is unacceptable. And we’re seeing disproportionate amounts of people really affected in rural areas and staggering numbers in the elderly population. And so I say all this not to be depressing, but to say we have work to do, and that is why we are here.”
Addiction recovery providers and advocates applauded the news.
“These recommendations are exactly the types of services we should be funding if we want to save as many lives as possible,” said Eddie Frierson of the New Jersey Harm Reduction Coalition. “Harm reduction is the best tool we have to prevent overdose deaths, and we have mountains of evidence and personal experience to prove it. Now we just need more dollars so every community in the state has access to this lifesaving care.”
GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
New Jersey Monitor is part of States Newsroom, a nonprofit news network supported by grants and a coalition of donors as a 501c(3) public charity. New Jersey Monitor maintains editorial independence. Contact Editor Terrence T. McDonald for questions: info@newjerseymonitor.com. Follow New Jersey Monitor on Facebook and X.
Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our website. AP and Getty images may not be republished. Please see our republishing guidelines for use of any other photos and graphics.
Dana DiFilippo comes to the New Jersey Monitor from WHYY, Philadelphia’s NPR station, and the Philadelphia Daily News, a paper known for exposing corruption and holding public officials accountable. Prior to that, she worked at newspapers in Cincinnati, Pittsburgh, and suburban Philadelphia and has freelanced for various local and national magazines, newspapers and websites. She lives in Central Jersey with her husband, a photojournalist, and their two children. You can reach her at [email protected].
New Jersey Monitor is part of States Newsroom, the nation’s largest state-focused nonprofit news organization.
New Jersey Monitor provides fair and tough reporting on the issues affecting New Jersey, from political corruption to education to criminal and social justice. We strive to hold powerful people accountable and explain how their actions affect New Jerseyans from Montague to Cape May.
New Jersey Monitor, PO Box 6843, Lawrenceville, NJ 08648
We’re part of States Newsroom, the nation’s largest state-focused nonprofit news organization.
DEIJ Policy | Ethics Policy | Privacy Policy
Luer Lock Syringe Use Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our website.